-
サマリー
あらすじ・解説
Published in New England Journal of Medicine the study details the MINT trial, a phase 3 clinical trial evaluating the efficacy and safety of inebilizumab for treating generalized myasthenia gravis (MG). #Neurology #Myasthenia
Published in New England Journal of Medicine the study details the MINT trial, a phase 3 clinical trial evaluating the efficacy and safety of inebilizumab for treating generalized myasthenia gravis (MG). #Neurology #Myasthenia